Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
McKesson (MCK) Q4 2022 Earnings Call Transcript
04:30am, Friday, 06'th May 2022 The Motley Fool
MCK earnings call for the period ending March 31, 2022.
McKesson (MCK) Lags Q4 Earnings Estimates
09:55pm, Thursday, 05'th May 2022 Zacks Investment Research
McKesson (MCK) delivered earnings and revenue surprises of -3.80% and 3.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
McKesson (MCK) Lags Q4 Earnings Estimates
07:34pm, Thursday, 05'th May 2022
McKesson (MCK) delivered earnings and revenue surprises of -3.80% and 3.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
A Peek Into The Markets: US Stock Futures Down Following Wednesday's Surge
09:34am, Thursday, 05'th May 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade. The Dow Jones gained more than 900 points in the previous session following an interest rate hike from the Federal Reserve. I
5 Stocks To Watch For May 5, 2022
08:26am, Thursday, 05'th May 2022 Benzinga
Some of the stocks that may grab investor focus today are:
Wall Street expects ConocoPhillips (NYSE: COP) to report quarterly earnings at $3.00 per share on revenue of $16.50 billion before the open
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD
05:49pm, Wednesday, 04'th May 2022 Zacks Investment Research
The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD
01:32pm, Wednesday, 04'th May 2022
The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
12:21pm, Monday, 02'nd May 2022 Zacks Investment Research
McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.
Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?
10:20am, Monday, 02'nd May 2022 Zacks Investment Research
Style Box ETF report for CLRG
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
07:02pm, Thursday, 28'th Apr 2022 Zacks Investment Research
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
04:35pm, Thursday, 28'th Apr 2022
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?
02:36pm, Monday, 18'th Apr 2022 Zacks Investment Research
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?
12:02pm, Monday, 18'th Apr 2022
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Illumina (ILMN) Hurt by Rising Costs, Tough Competition
12:44pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Regulatory complications are raising the legal expenses for Illumina (ILMN), thereby building pressure on the bottom line.
Here's Why You Should Retain Phibro (PAHC) Stock For Now
12:30pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Investors are optimistic about Phibro (PAHC) owing to the robust performances by its Animal Health and Mineral Health segments.
